A recent meta-analysis examined all blinded clinical trials that directly compared second-generation antipsychotics, including 76 trials with 13,558 participants.
Read More
A recent study investigated the relationship between the use of SSRIs prior to or during pregnancy and the development of gestational hypertension and preeclampsia.
Read More
Researchers (not paid by the drug company) examined data from GlaxoSmithKline’s database of clinical trials for lamotrigine (Lamictal) as a treatment for bipolar depression.
Read More
Health care reform is back on the national agenda with a vengeance. Obama made this a central part of his campaign platform and recently met with various insurance and medical groups to begin the lobbying and persuasion process. Why does the Obama administration appear to have high hopes for another attempt at universal health care? And what might such a system mean for psychiatrists?
Read More
Psychiatric treatment has been discriminated against by insurance companies for years. The recent passage of historic parity legislation may change this. Can you bring us up to speed on the history of this difficult relationship between insurance companies and psychiatrists?
Read More
Dr. Nissen, you have been at the forefront of those who believe that the FDA is not doing a good enough job of warning the public about adverse effects of drugs. What is the problem?
Read More
Dr. Aiken is the Editor in Chief of The Carlat Psychiatry Report; director of the Mood Treatment Center in North Carolina, where he maintains a private practice combining medication and therapy along with evidence-based complementary and alternative treatments; and Assistant Professor NYU Langone Department of Psychiatry. He has worked as a research assistant at the NIMH and a sub-investigator on clinical trials, and conducts research on a shoestring budget out of his private practice. Follow him on Twitter and find him on LinkedIn.